Clinical Trials Update: Sept. 7, 2010

(HealthDay News) -- Here are the latest clinical trials, courtesy of ClinicalConnection.com:

News in brief

Here are a selection of brief news items from this week’s paper edition, and possibly a few news briefs that didn’t make it in the paper.

Head Start For Migraine Sufferers

Psychological migraine treatment gives sufferers a confidence boost in their ability to self-manage their symptoms. For severe migraine sufferers, psychological treatments build on the benefits of drug therapy, according to a new study by Elizabeth Seng and Dr. Kenneth Holroyd from Ohio University in the US...

Bedford Laboratories to Begin Shipping Sumaptriptan Succinate Injection, 6mg (base)/0.5 mL Packaged in Pre-Filled ...

Bedford Laboratories⢠is excited to announce they have further diversified their product offerings with the addition of pre-filled syringes. FDA approval has been granted and Sumaptriptan Succinate Injection, 6mg /0.5 mL pre-filled syringes are now available. This is a very important product addition to their expanding portfolio of products.  Sumaptriptan Succinate Injection is indicated for ...

Memory Problems More Common In Men?

A new study shows that mild cognitive impairment (MCI) may affect more men than women. The research is published in the September 7, 2010, print issue of Neurology®, the medical journal of the American Academy of Neurology. Mild cognitive impairment is a condition in which people have problems with memory or thinking beyond that explained by the normal rate of aging. The study found that MCI was ...

Dr. Gott: Treatment for lupus seeks to control pain

Dr. Gott: Treatment for lupus seeks to control pain